HARPOON
Live / Registered — Registered — Section 8 accepted (as of 10 Sept 2026)
What this means for you
Registered since 08 Dec 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88587427
- Registration number
- 6217787
- Mark type
- Stylized text
- Filed
- 21 Aug 2019
- Published for opposition
- 03 Mar 2020
- Registered
- 08 Dec 2020
- Attorney of record
- Lisa Dellamura
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in oncology; pharmaceutical preparations and substances for the treatment or prevention of dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, stomach, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; anti-infectives; anti-inflammatories; vaccines
Owner
- Harpoon Therapeutics, Inc., South San Francisco, CA, US
- Harpoon Therapeutics, Inc., South San Francisco, CA, US
- Harpoon Therapeutics, Inc., South San Francisco, CA, US
Prosecution history
- 10 Sept 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 10 Sept 2026 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 08 Sept 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 13 Jul 2026 — TEAS SECTION 8 RECEIVED
- 08 Dec 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 17 Apr 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 17 Apr 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 17 Apr 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 17 Apr 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 17 Apr 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 08 Dec 2020 — REGISTERED-PRINCIPAL REGISTER
- 31 Oct 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 30 Oct 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 10 Oct 2020 — STATEMENT OF USE PROCESSING COMPLETE
- 24 Sept 2020 — USE AMENDMENT FILED